Clinical Trial Update: A Phase I Study of Mozobil in the Treatment of Patients With WHIMS [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial is evaluating Mozobil (plerixafor) for the treatment of WHIM syndrome, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Whim Syndrome

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Leukopenia, Neutropenia | Phase 1, Phase 2 | Status: RECRUITING